Latest Capital Raises News

MRG Metals has expanded its rare earth portfolio through the acquisition of the high-grade Garies Rare Earth Project in South Africa, while also progressing key projects in Mozambique, signalling a diversified growth strategy in critical minerals.

Alpha HPA Limited has successfully raised A$225 million through a fully underwritten equity placement, bolstered by strong institutional support, to fund the next phase of its high purity alumina project. This capital injection, combined with existing cash and government funding, positions the company to advance its Stage 2 construction and expand Stage 1 capacity.

Range International Limited has reported its strongest quarterly sales and production figures yet in Indonesia, while strategically pivoting towards a pallet rental model to secure more stable revenue streams.

Santa Fe Minerals has secured an 80% stake in four promising gold projects in Côte d’Ivoire, setting the stage for an active drilling campaign starting February 2026. The acquisition significantly broadens the company’s exploration footprint with high-grade targets already identified.

Alice Queen Limited is updating its Horn Island Gold Project valuation following a dramatic gold price increase, with a refreshed scoping study and resource estimate expected by mid-2026. The company has also raised $1 million to support exploration and development activities.

Oakajee Corporation has identified a new gold mineralised shear zone at its Paynes Find project in Western Australia, with assay results confirming promising gold grades. The company plans additional drilling to better define the zone, supported by a solid cash position and listed investments.

Neurizon Therapeutics has cleared a major regulatory hurdle with the FDA lifting the clinical hold on its lead drug NUZ-001 and secured a comprehensive $33 million funding package to advance its pivotal ALS trial.

Entropy Neurodynamics has successfully enrolled and dosed the first patient in its pioneering clinical trial of TRP-8803, an intravenous psilocin formulation targeting Binge Eating Disorder, while securing $6.1 million in new funding to accelerate development.

Yugo Metals has made promising progress with diamond drilling at its Sinjakovo project, intersecting silver-zinc-lead mineralisation, while securing $3.5 million in new funding and expanding its investor reach through a dual listing in Germany.

Neurotech International has secured a Rare Pediatric Disease Designation from the FDA for its lead drug NTI164 targeting Rett syndrome, alongside publishing promising clinical data and raising $8.7 million to fuel further development.

Solis Minerals has made a decisive leap in its Peruvian copper-gold exploration with the acquisition of the Cucho Project and a successful $5.9 million capital raise, setting the stage for an active 2026 drilling campaign.

FireFly Metals has significantly expanded its Green Bay Copper-Gold Project resource by 51%, backed by a substantial A$149 million equity raise, positioning the company for accelerated development and economic studies.